Enteral formulations for treatment of inflammation and infection

Details Enteral formulations for treatment of inflammation and infection Enteral formulations for treatment of inflammation and infection

1994-04-15

1995-03-14

Griffin, Ronald W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

4241951, 424DIG13, 426804, 426810, 514464, 514468, 514783, 514825, 514886, 514887, 514904, 514905, A61K 3138

Patent

active

053977785

ABSTRACT:
The present invention features saponin containing enteral formulations for treatment of infection and inflammation. These saponin containing formulations are particularly useful in conjunction with oils rich in .omega.3 polyunsaturated fatty acids such as fish oils and flax oil but also show benefits with .omega.6 rich oils such as borage oil, black currant seed oil, canola oil and rapeseed oil. These formulations may also contain a lignan from the sesamin family.

REFERENCES:
patent: 3901875 (1975-08-01), Park
patent: 3920440 (1975-11-01), Takaoka et al.
patent: 4317816 (1982-03-01), Arichi et al.
patent: 4339442 (1982-07-01), Takemoto et al.
patent: 4375480 (1983-03-01), Soma
patent: 4427694 (1984-01-01), Benecke et al.
patent: 4442092 (1984-04-01), McBrayer
patent: 4501734 (1985-02-01), Tanaka et al.
patent: 4649206 (1987-03-01), Namiki et al.
patent: 4708820 (1987-11-01), Namiki et al.
patent: 4722941 (1988-02-01), Eckert et al.
patent: 4752618 (1988-06-01), Mascioli et al.
patent: 4755504 (1988-07-01), Liu
patent: 4767626 (1988-08-01), Cheng
patent: 4774229 (1988-09-01), Jordan
patent: 4774343 (1988-09-01), Namiki et al.
patent: 4780475 (1988-10-01), Cerra et al.
patent: 4803153 (1989-02-01), Shibata et al.
patent: 4810726 (1989-03-01), Bistrian et al.
patent: 4920098 (1990-04-01), Cotter et al.
patent: 4966893 (1990-10-01), Pang et al.
patent: 4981844 (1991-01-01), Alexander et al.
patent: 5053387 (1991-10-01), Alexander
patent: 5055446 (1991-10-01), Alexander et al.
patent: 5166139 (1992-11-01), Bombardelli et al.
patent: 5180588 (1993-01-01), Shinmen et al.
patent: 5209826 (1993-05-01), Ozaki et al.
patent: 5211953 (1993-05-01), Shinmen et al.
patent: 5214062 (1993-05-01), Mark et al.
patent: 5229136 (1993-07-01), Mark et al.
patent: 5231085 (1993-07-01), Alexander et al.
patent: 5260336 (1993-11-01), Forse et al.
patent: 5270335 (1993-12-01), Akimoto et al.
patent: 5273965 (1993-12-01), Kensil et al.
Sugano and Akimoto, (1993), "Sesamin: A Multifunctional Gift From Nature", Journal of Chinese Nutrition Socity, vol. 18, pp. 1-11.
Shimizu et al., (1993), "Studies on Desaturase Inhibitors of Polyunsaturated Fatty Acid Biosynthesis", Eds: A Sinclair and R. Gibson, American Oil Chemists' Society, pp. 37-41.
Hirose et al., (1991), "Inhibition of cholesterol absorption and synthesis in rats by sesamin", JOurnal of Lipid Research, vol. 32, pp. 629-638.
Shimizu et al., (1991), "Sesamin Is a Potent and Specific Inhibitor of .DELTA.5 Desaturase in Polyunsaturated Fatty Acid Biosynthesis", Lipids, vol. 26, No. 7, pp. 512-516.
Salerno et al., (1991), "The Use of Sesame Oil and Other Vegetable Oils in the Inhibition of Human Colon Cancer Growth in Vitro", Anticancer Research, vol. 11, pp. 209-216.
Fink et al., (1990) "Laboratory Models of Sepsis and Septic Shock", Journal of Surgical Research, vol. 49, pp. 186-196.
Shimizu et al., (1989), "Production of Dihmo-.gamma.-linolenic Acid by Mortierella alpina 1S-4", JAOCS, vol. 66, No. 2, pp. 237-241.
Baker et al., (1983), "Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model", Surgery, vol. Aug. 1983, pp. 331-335.

Affiliated with

Also associated with

Rating

Enteral formulations for treatment of inflammation and infection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enteral formulations for treatment of inflammation and infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enteral formulations for treatment of inflammation and infection will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-713858